Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis (Q37766527)

22 August 2017

0 references

1 reference

title

Management of adult patients with acute lymphoblastic leukemia in first complete remission: systematic review and meta-analysis (English)

1 reference

22 August 2017

0 references

1 reference

1 reference

lymphoblastic leukemia

1 reference

4

Mical Paul

1 reference

22 August 2017

5

Isaac Ben-Bassat

1 reference

22 August 2017

2

Anat Gafter-Gvili

1 reference

22 August 2017

6

Ofer Shpilberg

1 reference

22 August 2017

Ron Ram

1

1 reference

22 August 2017

Liat Vidal

series ordinal

3

1 reference

22 August 2017

Pia Raanani

series ordinal

7

1 reference

22 August 2017

language of work or name

English

0 references

publication date

1 July 2010

1 reference

22 August 2017

1 reference

22 August 2017

116

1 reference

22 August 2017

14

1 reference

22 August 2017

3447-3457

1 reference

Donor search or autografting in patients with acute leukaemia who lack an HLA-identical sibling? A matched-pair analysis. Acute Leukaemia Working Party of the European Cooperative Group for Blood and Marrow Transplantation (EBMT) and the Internation

22 August 2017

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

Treatment of adult acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Progress in the treatment of adults with acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Treatment of acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Optimal management of adults with ALL.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute lymphoblastic leukemia in adults: an evidence-based review.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Allogeneic hematopoietic stem cell transplantation as part of postremission therapy improves survival for adult patients with high-risk acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Event-free survival and cost-effectiveness in adult acute lymphoblastic leukaemia in first remission treated with allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Myeloablative allogeneic versus autologous stem cell transplantation in adult patients with acute lymphoblastic leukemia in first remission: a prospective sibling donor versus no-donor comparison

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Prospective outcome data on 267 unselected adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia confirms superiority of allogeneic transplantation over chemotherapy in the pre-imatinib era: results from the International

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Commentary: Mendelian randomization--an update on its use to evaluate allogeneic stem cell transplantation in leukaemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Allogeneic bone marrow transplantation in adult acute lymphoblastic leukemia in first complete remission: a comparative study. French Group of Therapy of Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Adult acute lymphocytic leukemia study testing chemotherapy and autologous and allogeneic transplantation. A follow-up report of the French protocol LALA 87.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Better outcome of adult acute lymphoblastic leukemia after early genoidentical allogeneic bone marrow transplantation (BMT) than after late high-dose therapy and autologous BMT: a GOELAMS trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Allogeneic stem cell transplantation improves the outcome of adults with t(1;19)/E2A-PBX1 and t(4;11)/MLL-AF4 positive B-cell acute lymphoblastic leukemia: results of the prospective multicenter LALA-94 study

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Central nervous system involvement in adult acute lymphoblastic leukemia at diagnosis: results from the international ALL trial MRC UKALL XII/ECOG E2993

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Autologous stem cell transplantation in adults with acute lymphoblastic leukemia in first complete remission: analysis of the LALA-85, -87 and -94 trials

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia--results of the prospective multicenter LALA-94 trial

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow transplantation as postremission therapy. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukemia in first complete remission: a donor vs no donor comparison.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25136

7 January 2021

Identifiers

DOI

10.1002/CNCR.25136

1 reference

22 August 2017

1 reference